Torrey Pines Law GroupFree Consultation
≡
  • About Us
    • About Our Firm
    • The Advantages of Hiring Our Firm
    • Recent Successes
    • Client Testimonials
    • Careers
    • Diversity, Equity & Inclusion
    • Locations
    • Boston
      • Boston Patent Atorneys
      • Boston FDA Regulatory Counsel
      • Boston Technology Transactions
    • Irvine
      • Irvine Patent Atorneys
      • Irvine FDA Regulatory Counsel
      • Irvine Technology Transactions
    • Los Angeles
      • Los Angeles Patent Atorneys
      • Los Angeles FDA Regulatory Counsel
      • Los Angeles Technology Transactions
    • San Diego
      • San Diego Patent Atorneys
      • San Diego FDA Regulatory Counsel
      • San Diego Technology Transactions
    • Contact
  • Professionals
    • Meet Our Team
    • Randy Berholtz, MLitt, MBA, JD
    • Robert Buchanan, PhD, JD
    • Kevin Buckley, JD
    • Frank Chen, PhD
    • Doranne Frano, MS, MBA
    • Dmitry Kryndushkin, PhD
    • Mark Malek, JD
    • James McFarland, JD
    • Eleanor Musick, JD
    • Shihong Nicolaou, PhD
    • Steven Stupp, PhD
    • Kyle Welch, JD
    • Fawn Zhang, PharmD, JD
    •  
    • Administration
    • Jaenna Barnard
    • Carina Collins
    • Amy Stedman
    • Cyndi Willis
    •  
    • Foreign Associates
  • Intellectual Property
    • Comprehensive IP Protection
    • Patent Preparation & Prosecution
    • ● Artificial Intelligence Patents
    • ● Biotechnology Patents
    • ● Chemistry Patents
    • ● Convergence Technology Patents
    • ● In Vitro Diagnostics Patents
    • ● Lasers & Optics Patents
    • ● Medical Device Patents
    • ● Pharmaceutical Patents
    • ● Pharmaceutical Lifecycle Management
    • ● Semiconductor Patents
    • ● Software Patents
    • ● Telecommunications Patents
    • ● Telemedicine Patents
    • National Phase Entry (PCT)
    • IP Litigation
    • IP Opinions & Counseling
    • IP Resources
      • Patent Rights Overview
      • International Patent Law
      • U.S. Patent Law
        • Patent Eligibility
        • Novelty
        • Obviousness
        • Written Description
        • Enablement
      • Anatomy of a U.S. Patent
        • Utility Patent
        • Design Patent
        • Plant Patent
      • Trademark Law
      • Copyright Law
      • Trade Secrets
      • Know How
      • Intangible Assets
  • Tech Transactions
    • International Technology Transactions
    • Corporate Strategy
    • Business Agreements
    • Transactional Due Diligence
    • Intellectual Property Agreements
    • Intellectual Property Due Diligence
    • Regulatory Agreements
    • Regulatory Due Diligence
  • FDA Regulatory
    • Global Strategic Counseling
    • Dossier Submissions
    • Quality Compliance (ISO)
    • CE Mark - MDR Services
    • Digital Health
    • Hatch-Waxman & Biosimilars
    • Labeling, Advertising & Promotion
    • Reimbursement & Health Economics
  • Experience
    • Our International Experience
    • Multinational Companies
    • Public Companies
    • Private Companies
    • Research & Academic Institutions
    • Hospitals & Physicians
    • Startups & Entrepreneurs
  • Contact
background
Hide
 
Show
  • background
  • torrey-pines-broken-hill
  • torrey-pines-sunset

Intellectual Property Due Diligence

Intellectual Property Due Diligence

Assessing the strength and value of a company's IP assets is often considered a critical element to many corporate and business transactions, including mergers and acquisitions, investment opportunities, licensing negotiations, and technology transfer.

Torrey Pines Law Group attorneys have experience with conducting IP due diligence and valuation in a variety of industries and technologies. We can perform detailed research on all of the IP assets involved in a pending transaction, and help the client better understand the strengths and weaknesses of such assets. By way of example, our attorneys:

  • Led a team of IP, corporate, and tax attorneys in due diligence and deal consultation for a nine-figure Fortune 500® pharmaceutical acquisition.
  • Led the pharmaceutical product clearance and due diligence for Fortune 500® ANDA applicant.
  • Performed IP due diligence in seed, angel, and venture capital investments as well as initial public offerings for startup biotechnology and pharmaceutical companies.
  • Performed all IP due diligence for an international company related to in-licenses of small molecule pharmaceutical and large molecule pharmaceutical assets originating in China, Korea, Japan, Taiwan, Europe, and Canada.
  • Performed patent due diligence for an international specialty chemical manufacturer related to in-licensing, sub-licensing, and re-sale of in vitro diagnostics and platform technologies.

For information on these and other legal, regulatory, and business matters, please contact us.

≡
  • Business Strategy & Technology Transactions
  • Corporate Strategy
  • Business Agreements
  • Transactional Due Diligence
  • Intellectual Property Agreements
  • Intellectual Property Due Diligence
  • Regulatory Agreements
  • Regulatory Due Diligence

Chambers Spotlight California 2025 Torrey Pines Law Group   Clio Reisman Award Torrey Pines Law Group COPYRIGHT © , TORREY PINES LAW GROUP, PC. ALL RIGHTS RESERVED. | LEGAL NOTICES | SITE MAP

Torrey Pines Law Group, PC serves technology innovators with protecting intellectual property, obtaining regulatory approvals and clearances, and making deals and closing technology transactions throughout the U.S., including in major technology hubs such as San Diego, San Francisco, Palo Alto, San Jose, Silicon Valley, Boston, Cambridge, Chicago, Minneapolis, Houston, Dallas, Atlanta, Denver, Seattle, Portland, Boulder, Orlando, the Research Triangle (Raleigh, Durham, and Chapel Hill), the Mid-Atlantic (New Jersey, New York, Philadelphia, Maryland, Virginia, and Washington, DC), Pittsburgh, Cleveland, Ann Arbor, and throughout Southern California in Los Angeles, Orange County, Irvine, Torrey Pines, Sorrento Valley, and La Jolla.

We have experience with international intellectual property, regulatory and transactional matters pending in Beijing, Shanghai, Shenzhen, and Guangzhou China; Tokyo, Japan; Berlin, Munich and Frankfurt Germany; Tel Aviv Israel; Mumbai, Bengaluru, and New Delhi India; London and Edinburgh United Kingdom; Vancouver, Toronto, Calgary and Montreal Canada; Dublin, Ireland; Cape Town, South Africa; Mexico City and Tijuana Mexico; Brussels, Belgium; Copenhagen, Denmark; Paris, France; Madrid and Barcelona Spain; Moscow, Russia; Santiago, Chile; Montevideo, Uruguay; Buenos Aires, Argentina; Sao Paulo and Rio de Janeiro Brazil; Seoul, South Korea; Taipei, Taiwan; Hong Kong; Hanoi, Vietnam; Bangkok, Thailand; Kuala Lumpur, Malaysia; Milan, Italy; Singapore; Sydney, Melbourne, Perth and Adelaide Australia; Auckland, New Zealand; Oslo, Norway; Stockholm, Sweden; Helsinki, Finland; Kiev, Ukraine; Budapest, Hungary; Vienna, Austria; Prague, Czechia; Geneva and Lausanne Switzerland; Bahrain; Doha, Qatar; Abu Dhabi and Dubai UAE; and Jeddah, Saudi Arabia.